Sierra Capital LLC Raises Holdings in CVS Health Co. (NYSE:CVS)

Sierra Capital LLC lifted its position in CVS Health Co. (NYSE:CVS) by 51.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,193 shares of the pharmacy operator’s stock after acquiring an additional 3,800 shares during the period. Sierra Capital LLC’s holdings in CVS Health were worth $704,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Livelsberger Financial Advisory bought a new position in CVS Health during the 3rd quarter valued at approximately $31,000. First Community Trust NA increased its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. bought a new stake in CVS Health in the 3rd quarter worth about $33,000. ORG Partners LLC increased its holdings in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 592 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group grew its stake in shares of CVS Health by 71.0% during the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 247 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 2.2 %

CVS Health stock traded down $1.27 during trading on Tuesday, reaching $56.90. 5,756,991 shares of the company were exchanged, compared to its average volume of 11,211,516. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The company has a market capitalization of $71.43 billion, a P/E ratio of 10.22, a PEG ratio of 0.93 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock’s 50 day simple moving average is $59.85 and its two-hundred day simple moving average is $60.32.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter last year, the business posted $2.21 earnings per share. The firm’s revenue was up 2.6% compared to the same quarter last year. On average, equities research analysts expect that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a $0.665 dividend. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.67%. CVS Health’s dividend payout ratio is currently 46.75%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CVS shares. Evercore ISI boosted their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Truist Financial upped their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Barclays raised CVS Health from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $63.00 to $82.00 in a report on Thursday, October 10th. Deutsche Bank Aktiengesellschaft decreased their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.